Jacob Sands
Assistant Professor of Medicine at Harvard Medical School
Biography
Harvard Medical School
Jacob Sands, M.D., is a thoracic medical oncologist at Dana-Farber Cancer Institute and an instructor of medicine at Harvard Medical School. He received his medical degree from the University of Cincinnati before completing residency in internal medicine and fellowship training in hematology/oncology at the University of California, Davis. Dr. Sands joined Dana-Farber Cancer Institute in 2017 where he sees individuals with lung cancer and leads the small cell lung cancer clinical research program.
Dr. Sands has an interest in lung cancer diagnostics and therapeutics with ongoing protocol development in non-small cell and small cell lung cancers. He is a member of the NCCN guidelines committees on small cell lung cancer and lung screening. Dr. Sands has given many invited talks on various aspects of lung cancer as well as talks with the public and patient advocacy organizations, such as a discussion on clinical trials for the Bonnie Addario Foundation “Living Room.” He serves on the GO2 Foundation (merged Bonnie Addario Lung Cancer Foundation and Lung Cancer Alliance) Scientific Leadership Board.
During the five years he was on staff at Lahey Hospital & Medical Center, Dr. Sands was a member of the steering committee that initiated a community benefit of lung screening, which developed into a lung screening program that many consider to be a model for other institutions. He has been an invited speaker on lung screening to many venues and serves as Treasurer of the Rescue Lung Rescue Life Society, an organization focused on increasing implementation of lung screening and pioneering early detection innovations.
Clinical Interests
- Immunotherapy
- Lung cancer
- Lung screening
- Non-small cell lung cancer
- Small cell lung cancer
Education
Medical School
- University of Cincinnati College of Medicine
Board Certifications
- Medical Oncology, 2012
Videos
Lung Cancer Living Room - March 18, 2022
Selective Inhibition of Oncogenic Transcription and Other Approaches in the Treatment of SCLC
COVID-19: Impact on Caring for Your Patients With Lung Cancer - Episode 1
Dr. Sands on the Rationale to Explore DS-1062 in Advanced NSCLC
Jacob Sands, M.D., Dana-Farber Cancer Institute, on lung cancer screening and smoking cessation.
Jacob Sands, M.D., Dana-Farber Cancer Institute, on screening catching lung cancer earlier.
Workup and Management of Nondriver Metastatic Lung Cancer
Fighting Advanced Lung Cancer
Making the Most of Treatment Advances in SCLC
Lung Cancer Living Room™ - About Clinical Trials w/ Dr. Jacob Sands - Oct 16, 2018 - Full 2-Hr Ep
Dr. Sands on the FDA Approval of Lurbinectedin in Small Cell Lung Cancer
Dr. Jacob Sands on Lung Cancer Treatment | Dana-Farber Cancer Institute
Integrating New Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes
Lung Cancer Living Room™ - The Importance of Clinical Trials - October 16, 2018 - Half Hr Episode
Lung Cancer Living Room - Best of ASCO 2019 with Dr. Jacob Sands - 7/16/19 - Full 2hr
Read about executive education
Other experts
Popular Courses
Leading People and Teams
ESMT
Berlin, Germany
May 28
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
Looking for an expert?
Contact us and we'll find the best option for you.